Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Phase 2: Proof of Efficacy (2021-2023) Trial Design and Execution Two Phase 2 trials were initiated in 2021 and represented the most critical milestone in retatrutides development: Phase 2 Obesity Trial (NCT04881706) : A 48-week, randomized, double-blind, placebo-controlled, dose-ranging study in 338 adults with obesity or overweight
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
doi: 10.1093/ecco-jcc/jjx009 25 TorresJBonovasSDohertyGKucharzikTGisbertJPRaineTet al
After an initial assessment, your practitioner will collaborate with you to put together a personalised treatment strategy aligned with your goals
US$ 23.55
US$ 28.25
US$ 26.34
US$ 25.81
US$ 22.45
US$ 29.37
